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Abstract Objective: Intensive
insulin therapy is associated with the
risk of hypoglycemia and increased
costs of material and personnel. We
thereforeevaluatedthe safety and efﬁ-
ciency of a computer-assisted glucose
control protocol in a large population
of critically ill patients. Design and
setting: Observational cohort study
in three intensive care units (32 beds)
in a 1,300-bed university teaching
hospital. Patients: All 2,800
patients admitted to the surgical,
neurosurgical, and cardiothoracic
units; the study period started at each
ICU after implementation of Glucose
Regulation for Intensive Care
Patients (GRIP), a freely available
computer-assisted glucose control
protocol. Measurements and results:
We analysed compliance in relation
to recommended insulin pump rates
and glucose measurement frequency.
Patients were on GRIP-ordered pump
rates 97% of time. Median meas-
urement time was 5 min late (IQR
20min early to 34min late).
Hypoglycemia was uncommon (7%
of patients for mild hypoglycemia,
< 3.5mmol/l; 0.86% for severe
hypoglycemia, < 2.2mmol/l).
Our predeﬁned target range
(4.0–7.5mmol/l) was reached after
a median of 5.6h (IQR 0.2–11.8) and
maintained for 89% (70–100%) of
the remaining stay at the ICU. The
number of measurements needed
was 5.9 (4.8–7.3) per patient per day.
In-hospital mortality was 10.1%.
Conclusions: Our computer-assisted
glucose control protocol provides safe
and efﬁcient glucose regulation in
routine intensive care practice. A low
rate of hypoglycemic episodes was
achieved with a considerably lower
number of glucose measurements
than used in most other schemes.
Keywords Insulin · Glucose · Criti-
cally ill · Computer decision support
Introduction
Glucose control with intensive insulin therapy in critically
ill medical and surgical patients reduces morbidity and
mortality [1, 2]. However, this therapy carries the risk
of hypoglycemia. Although little is known about the
impact of hypoglycemia, cases with severe sequelae have
been reported [3–5]. Recently a retrospective review
found that the occurrence of a single episode of hypo-
glycemia is related to mortality [6]. Due to the high rate of
insulin-induced hypoglycemia a multicenter trial has been
stopped, and negative results have led to debate about
the overall beneﬁt of glucose control [7, 8]. Therefore
a meticulous scheme of glucose measurements and sub-
sequent insulin-dosing adjustments must be implemented.
Such a scheme should lead to adequate control with as
few glucose measurements as possible with minimal risk
of hypoglycemia.
Many insulin infusion protocols have been proposed,
but performance is difﬁcult to compare [9], and the size of
reported patient cohorts is often small. As hypoglycemia
is and should be a rare event, no ﬁrm conclusions can be
drawn from small populations. Furthermore, a research
setting in which a protocol is tested on selected patients1422
may not reﬂect the performance of a protocol when used
in routine practice. We implemented a computer-assisted
glucose control system in routine practice and evaluated
its safety and efﬁciency in a large cohort of unselected
consecutive patients in three ICUs.
Materials and methods
GRIP computer program
The Glucose Regulation for Intensive Care Patients
(GRIP) computer program gives recommendations on
exact insulin pump rates and glucose measurement fre-
quency for all patients. It also acts as watchdog against
overdue measurements. Initial results and a description
of the GRIP computer program have previously been
reported [10]. In short, the GRIP program is installed on
a computer directly next to the point of care blood gas
analyzer. By default the computer shows an overview
of the ICU. The colors of the beds make clear whether
a speciﬁc action (such as taking a new blood glucose
or modifying an insulin pump) should be performed
at a certain bed. New glucose values are automatically
queried from the hospital information system. These
values are combined with clinical data obtained from the
nurse, and recommendations on both the insulin pump
rate and the measurement interval can be calculated at any
moment. The algorithm employed by GRIP is based on
both the level and the change in recent glucose values.
A more detailed description of the algorithm is given in
the accompanying Electronic Supplementary Material.
GRIP was designed with practical applicability in mind;
where possible, we aimed at limiting the number of blood
glucose measurements needed and thus the time spent on
glucose control. The total turn-around time for a nurse,
from glucose measurement to ﬁnal pump change was
measured to be 4min.
In 2005 we implemented an improved version that
incorporates more safety features, such as label printing,
rendering the entire procedure paperless. The complete
source code of the GRIP computer program is freely
available from the website http://grip-glucose.sf.net/. The
insulin dosing of GRIP is ﬂexible with regard to its target
value. In view of the debated value of aiming for true
Fig.1 Time chart of patient
inclusion per ICU. The dark
colored squares indicate a
‘run-in’ period. The patients
treated by GRIP in these periods
were not analyzed in this study
normoglycemia (4.4–6.1mmol/l), the medical directors
(M.N., B.L., J.R.) preferred a more lenient glucose range
of 4.0–7.5mmol/l, and therefore GRIP was conﬁgured to
aim for a glucose level of 6.5mmol/l. It should be noted
that changing the algorithm’s target value is trivial.
Implementation of GRIP
All ICUs that have implemented GRIP are part of the
University Medical Center of Groningen, a 1,300-bed
tertiary university hospital. All three ICUs are closed-
format ICUs with a nursing to patient ratio of one-to-one.
The three units are teaching general surgery, anesthe-
siology, and internal medicine residents, and fellows in
intensive care medicine. GRIP was ﬁrst implemented at
the surgical ICU [10], followed by the cardiothoracic
and neurosurgical ICU. In dialog with staff the initial
target level was 7.0mmol/l for the cardiothoracic ICU
and 7.5mmol/l for the neurosurgical ICU. Nurses were
trained by a “teach-the-teacher” principle, where two or
three nurses of each ICU were trained at the surgical ICU,
after which they taught the colleagues at their own unit.
After a run-in period the GRIP target level was lowered to
6.5mmol/l.
Patients
We included 2,800 admissions with 73,188 glucose meas-
urements for analysis; Table1 presents patients’ charac-
teristics. We recorded baseline demographics, reason for
admission, and severity of illness as measured by Acute
Physiology and Chronic Health Evaluation (APACHE) II
scores [median 14, interquartile range (IQR) 10–19]. We
excluded the patients who were treated by GRIP in any
of the run-in periods. Figure1 shows a patient selection
diagram. All patients were managed by GRIP. Orders of
GRIP could be overruled at the discretion of the physician
at any time, or a patient could be taken out of GRIP alto-
gether. The latter happened structurally with patients who
had recoveredenough to be taking meals. During intermit-
tent invasive interventions insulin was stopped. The local
institutional review board approved this study.1423
Surgical ICU Thoracic ICU Neurosurgical ICU
(n=1,073, 38%) (n=1,597, 57%) (n=130, 5%)
Treatment period Feb. 2005–June 2007 Jan. 2006–June 2007 Mar. 2007–June 2007
Age (years) 62 (50–72) 66 (57–74) 55 (46–65)
Male sex 663 (62%) 1,096 (69%) 76 (62%)
APACHE II 14 (10–19) 14 (10–18) 12 (7–17)
Reason for admission
Cardiothoracic surgery 13 (1.2%) 1,303 (82%) 1 (0.8%)
Abdominal surgery 512 (48%) 17 (1.1%) 9 (6.9%)
Neurological 67 (6.2%) 24 (1.5%) 103 (79%)
Cardiac arrest 10 (0.9%) 137 (8.6%) 1 (0.8%)
Trauma 150 (14%) 12 (0.8%) 5 (3.8%)
Vascular surgery 106 (10%) 18 (1.1%) 0 (0%)
Medical 57 (5.3%) 30 (1.9%) 8 (6.2%)
Posttransplant 45 (4.2%) 10 (0.6%) 0 (0%)
Miscellaneous 113 (11%) 46 (2.9%) 3 (2.3%)
In-hospital mortality 147 (14%) 117 (7.3%) 19 (15%)
Total number of patient-days 8,359 5,137 752
Admission glucose (mmol/l) 7.8 (6.5–9.5) 8.6 (7.3–10) 7.5 (6.5–8.9)
Time to reach target range (h) 4 (0–9) 9 (2–13) 2 (0–6)
Glucose after 24h (mmol/l) 6.7 (6.0–7.4) 6.5 (5.9–7.2) 6.8 (6.1–7.7)
Glucose SD (mmol/l) 1.1 (0.7–1.7) 1.3 (0.9–1.8) 1.0 (0.7–1.4)
Table 1 Patient characteristics
Glucose parameters
Glucose measurements were performed in arterial blood
samples when an arterial line was present and in venous
blood otherwise. All ICUs had a point-of-care blood
gas analyzer on which glucose measurements were per-
formed (ABL 700 or 800 series, Radiometer, Copenhagen,
Denmark). For each glucose measurement the recom-
mended measurement time was compared with the actual
measurement time. We classiﬁed these times in lowest,
middle two, and highest quartiles. For measurements
in each group we determined whether the glucose level
was in the desired range, and what the change in insulin
pump rate was after that measurement. Actual pump
rates were compared to the recommended pump rate
at each time point. We determined the linearly interpo-
lated glucose value of each patient at 3-h intervals after
admission for the ﬁrst 48h to visualize the general de-
crease in glucose achieved by GRIP directly after admis-
sion to the unit. Low glucose values were scored as mild
hypoglycemia (<3.5mmol/l) or severe hypoglycemia
(< 2.2mmol/l) and expressed as the proportion of all
patients, and as the number of episodes per 1,000 patient-
days.
To assess the ability of the program to reduce hy-
perglycemia we determined the time from admission
until the ﬁrst measurement that was in our target range
(4.0–7.5mmol/l). We also determined the amount of
time spent within the target range, both for the full
length of stay and for the period after ﬁrst reaching
the target range. We also calculated the hyperglycemic
index, a measure of overall hyperglycemia [11]. Recently
glucose variability has been proposed as control target of
glucose management [12]. We therefore determined blood
glucose variability by taking the standard deviation of all
measurements of a patient.
Statistics
All statistics were calculated with R version 2.2.4
(http://www.r-project.org). Variables are presented as
medians and IQR. Comparisons between groups were
made with the Mann–Whitney U-test, Fisher’s exact
test, or χ2 test. A p-value less than 0.05 was considered
statistically signiﬁcant.
Results
Glucose control
Median time between patient admission and the ﬁrst
glucose entered into GRIP generating a recommendation
was 21min (6–65). Compliance with GRIP-recommended
pump rates was 97%. Compared with the recommended
measurement time, the median measurement was 5min
late (IQR 20 min early to 34 min late). Table 2 shows
characteristics of glucose measurements and insulin pump
interventions for early, on-time, and late measurements.
Incidence of measurements less than 4.0mmol/l was
slightly lower with early than on-time measurements
(p= 0.04), but late measurements were more often low
(p= 0.03). Hypoglycemia was uncommon, with 0.86%
of patients experiencing a glucose level lower than
2.2mmol/l during any moment of their stay and 7% for
a level of 3.5 mmol/l. Per 1,000 patient-days of ICU stay
there were 1.6 measurements lower than 2.2mmol/l and1424
Early 18,357 On time 36,805 Late 18,026
(25%) (50%) (25%)
Time >20 min early −2 0m i nt o+ 3 4m i n >34min late
Glucose level (percentage
of time group)
Hypo (<2.2mmol/l) 0.03% 0.03% 0.07%
Low (2.2–4mmol/l) 0.8% 1.0% 1.3%
In range (4–7.5mmol/l) 74% 66% 70%
High (>7.5mmol/l) 25% 33% 29%
Insulin change (percentage
of time group)
Decrease >1IU/h 6.3% 11.9% 10.1%
Decrease 0.5–1IU/h 7.3% 9.9% 9.1%
Small change (–0.5 to +0.5IU/h) 68% 52% 58%
Increase 0.5–1IU/h 10.2% 12.5% 10.7%
Increase >1IU/h 8.1% 13.9% 11.7%
Table 2 Compliance with
measurement time: the lowest
(early), middle two (on time),
and highest quartile (late). For
each category the number of
measurements in range is shown
and how much the pump rate
was adjusted after that
measurement. Overall
distribution of glucose levels and
insulin changes was different for
each group (χ2 test, p<0.001)
14.4 measurements lower than 3.5mmol/l. For compari-
son with other studies, which often report the proportion
of hypoglycemic measurements instead of patients, the
percentage of measurements lower than 2.2mmol/l was
0.04%.
Figure2 graphically shows glucose control directly
after admission to the ICU. Admission glucose de-
Fig.2 Median and interquartile
range of glucose levels and
insulin pump rates during the
ﬁrst 48h of ICU stay
creased from 8.3mmol/l (6.9–9.8) to 6.6 (6.0–7.4) at 24h
(p<0.001). Time from admission to a value within the
desired range was 5.6h (0.2–11.8).After that time patients
stayed within range for 89% (70–100%)of their remaining
stay. Due to the inclusion of a signiﬁcant number of short
stay patients, for which the time to establish initial control
represents a relatively large part of their total stay, the1425
overall time in range was 67%. The hyperglycemic index
was 1.24mmol/l (0.8–1.76). The patients in the lowest
quartile of time in range had higher APACHE II scores,
higher insulin doses, less compliance with the recom-
mended insulin rate, more frequent measurements, and
a higher incidence of hypoglycemia. Median number of
glucose measurements per day of stay was 5.9 (4.7–7.3),
i.e., once every 245 min. The glucose variability was
1.22mmol/l (0.8–1.75).
Discussion
This study evaluated computer-assisted glucose control in
routinepracticeovera3-yearperiodatthreeICUswith dif-
ferent patient populations. With a reasonable glucose tar-
get level, we found that glucose control was adequate and
safe, with low rates of hypoglycemia.Importantly, the pro-
tocol was feasible with six measurements per patient per
day, and compliance to the protocol was high.
Safety is a major concern in contemporary health
care. While the efﬁcacy of glucose control is debated,
implementation should be particularly safe [8]. Reducing
the possibility of human cognitive failure is a generic
way to improve safety in health care [13]. Prior to our
study it was shown that standardization by paper protocol
improves glucose control, and that computer-assisted
protocols are feasible and lead to better compliance than
protocols on paper [14, 15]. Recommendations of pump
rates and measurement intervals and the notiﬁcation of
expiration of the interval, combined with the possibility of
overruling, provide a ﬂexible standardization of glucose
control in the ICU.
Comparison with protocols from the literature is dif-
ﬁcult because of wide variations in target glucose levels,
patient populations, and metrics of control reported [9].
We performed a literature search to ﬁnd all computerized
glucose protocols designed for ICU patients and tested
in at least 20 patients. We summarize these ﬁndings in
Table3. Similar to what is reported for paper protocols,
reported target ranges, patient populations, and meas-
urement means vary greatly. However, we can conclude
that compared with the studies published thus far, the
present study is one of the largest to date and compares
favorably in terms of occurrence of hypoglycemia and
achievement of the target range. Interestingly, only one
other published computer protocol [16] aiming at achiev-
ing control with a low measurement frequency. This is
remarkable, as glucose control with a high measurement
frequency is associated with signiﬁcant costs in terms of
nursing effort and supplies [17]. The glucose variability,
which has recently been proposed as an important de-
terminant of control [12], was 1.22mmol/l in our large
cohort. This is lower than the ﬁgures published previ-
ously, which were 1.7±1.3 in survivors and 2.3± 1.6 in
nonsurvivors [12].
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The protocol GRIP used is published as open source,
and the program can therefore be used freely by any hos-
pital able to implement the bridge between GRIP and the
hospital information system. We recognize that few hospi-
tals have suchresources,and we therefore provideda more
detailed description of the algorithm in an online supple-
ment, including typical recommendations for two exam-
ple patients. Computer-based protocols published to date
broadly fall into three categories: ﬂow-chart based, empir-
ical formula based, and model based. Most paper proto-
cols that are directly computerized fall into the ﬁrst cate-
gory. GRIP uses a formula empirically derived from many
protocols and expert knowledge. Model-based approaches
model glucosedynamicsin different compartmentsand try
to predict future glucose levels and insulin need from that.
There have been no direct comparisons of different com-
puter algorithms to date, and more research is needed to
identify the best approach.
Ourstudyhasanumberofstrengths.We studiedalarge
number of patients treated in routine practice. This pro-
vides a less biased view on true performance and rate of
hypoglycemia than studies of glucose protocols in a re-
search setting. The low number of measurements required
by GRIPmakesthe protocolless time consumingthan pro-
tocols with hourly measurements. The low average num-
ber of measurements GRIP requires is mainly caused by
the ﬂexibility ofthe intervalalgorithm.GRIP performsfre-
quent measurements when needed, but this is counterbal-
anced by identiﬁcation of stable periods during a patient’s
stay (e.g., with steady glucose levels, full caloric intake
and low insulin dose) during which much longer intervals
can safelyberecommended.Anotherstrengthis ouranaly-
sis of actual compliance to the protocol. Prior publications
of protocolsrarely mentioncompliancemetrics. Goodper-
formance attributed to a protocol that is violated often by
nurses (by for instance measuring glucose earlier than rec-
ommended) can lead to disappointing results when strictly
followed at another unit. In our analysis we ﬁnd no struc-
tural violation of the protocol in terms of early and late
measurements, and only late measurements were associ-
ated with more glucose values that were out of range.
Our study also has a number of limitations. Our choice
of target glucose level (6.5 mmol/l) may be regarded as ei-
ther low or high, as the optimal target glucose level is cur-
rently an open question [18–20]. True adherence to nor-
moglycemia would require a lower target range than we
used. The number of measurements asked for by GRIP
depends on the expected risk of hypoglycemia, which be-
comes higher when aiming for a lower target. We there-
fore expect that a lower target level would increase GRIP’s
recommended measurement frequency without a signiﬁ-
cant increase in hypoglycemic episodes, but we have not
yet tested this. Clinical decision support tools may be less
likely to be successful in a setting in which they were not
developed [21]. As the ICUs in our center function inde-
pendently, and the development process has been limited
solely to the surgical ICU, we expect that limitations of
generalizability would have been uncovered in the imple-
mentation process, or would have been shown by inferior
performance on the two other ICUs.
A computer program also brings beneﬁts that we did
not study, such as straightforward auditing of performance
and easy incorporation of future changes in practice. For
instance, when newly published evidence would favor
a different target range, a quick adoption of the new pre-
ferredpracticeis possiblewithoutgoingthrougha learning
period for nurses and physicians. In conclusion, our study
shows that a computer-assisted protocol can safely and
efﬁciently guide glucose control at intensive care units in
routine practice.
Open Access. This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are credited.
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